Why the study?
Although skeletal muscle mesenchymal progenitors support regeneration, under pathological conditions they contribute to intramuscular adipose tissue accumulation, and how their fate is determined remains unelucidated.
Ror2-mediated signaling elicited by differential Wnts (Wnt11 and Wnt5b) plays a critical role in determining the pathological fate of muscle mesenchymal progenitors, leading to intramuscular adipose tissue accumulation.
May promote IMAT in muscle disease; hypothesis-generating in animal models, requires human validation.
Skeletal muscle mesenchymal progenitors (MPs) play a critical role in supporting muscle regeneration. However, under pathological conditions, they contribute to intramuscular adipose tissue accumulation, involved in muscle diseases, including muscular dystrophy and sarcopenia, age-related muscular atrophy. How MP fate is determined in these different contexts remains unelucidated. Here, we report that Ror2, a non-canonical Wnt signaling receptor, is selectively expressed in MPs and regulates their pathological features in a differential ligand-dependent manner. We identified Wnt11 and Wnt5b as ligands of Ror2. In vitro, Wnt11 inhibited MP senescence, which is required for normal muscle regeneration, and Wnt5b promoted MP proliferation. We further found that both Wnts are abundant in degenerating muscle and synergistically stimulate Ror2, leading to unwanted MP proliferation and eventually intramuscular adipose tissue accumulation. These findings provide evidence that Ror2-mediated signaling elicited by differential Wnts plays a critical role in determining the pathological fate of MPs.
No takes yet. Share an insight, caveat, or question.
Kamizaki et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: